The average stock forecast for
Samsung Biologics Co Ltd (207940.KS) in the next 12 months is 1,376,556.50 KRW. This price target corresponds to an upside
of
37.66%. The range of stock forecasts for 207940.KS is 1,161,500.00 - 1,680,000.00 KRW.
Based on the ratings of 30 analysts, the consensus recommendation for 207940.KS is
BUY.
| Target |
Low |
Average |
Median |
High |
| Price (KRW) |
1,161,500.00 |
1,376,556.50 |
1,346,400.00 |
1,680,000.00 |
| Upside |
16.15% |
37.66% |
34.64% |
68.00% |